Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Serenus.AI is a private healthcare AI company developing patented generative AI and clinical decision-support software to improve medical referrals, prior authorizations, and treatment-pathway decisions. Its products are designed for payers, providers, and patients, with an emphasis on automating case-by-case medical reviews, prioritizing waiting lists, and reducing unnecessary procedures and administrative burden. The company markets Prior-Auth360 for payers/employers, PPW for providers and physicians, MyMedicalOwl for patients, and an EMR API for integration into medical record workflows. Serenus.AI operates in multiple specialties including orthopedics, oncology, cardiology, gastroenterology, otolaryngology, obstetrics/gynecology, neurosurgery, oral surgery, plastics, ophthalmology, and urology. The business appears to be commercial-stage software rather than a drug developer, with activity reported in Israel, the UK, Europe, and the US.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Serenus.AI.